S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Laser breakthrough could send stock soaring 2,467% (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
The Ultimate Passive Income Play (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Laser breakthrough could send stock soaring 2,467% (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
The Ultimate Passive Income Play (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Laser breakthrough could send stock soaring 2,467% (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
The Ultimate Passive Income Play (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Laser breakthrough could send stock soaring 2,467% (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
The Ultimate Passive Income Play (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi

Phoenix Biotech Acquisition (PBAX) Competitors

$5.85
+0.26 (+4.65%)
(As of 02/14/2024)

PBAX vs. ADRT, WAVS, MCAG, QOMO, OLIT, BRAC, TGVC, NOVV, AIB, and GLST

Should you be buying Phoenix Biotech Acquisition stock or one of its competitors? The main competitors of Phoenix Biotech Acquisition include Ault Disruptive Technologies (ADRT), Western Acquisition Ventures (WAVS), Mountain Crest Acquisition Corp. V (MCAG), Qomolangma Acquisition (QOMO), OmniLit Acquisition (OLIT), Broad Capital Acquisition (BRAC), TG Venture Acquisition (TGVC), Nova Vision Acquisition (NOVV), AIB Acquisition (AIB), and Global Star Acquisition (GLST). These companies are all part of the "holding & other investment offices" industry.

Phoenix Biotech Acquisition vs.

Phoenix Biotech Acquisition (NASDAQ:PBAX) and Ault Disruptive Technologies (NYSE:ADRT) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phoenix Biotech Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ault Disruptive Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phoenix Biotech AcquisitionN/AN/AN/AN/AN/A
Ault Disruptive TechnologiesN/AN/A-$130KN/AN/A

In the previous week, Phoenix Biotech Acquisition's average media sentiment score of 0.00 equaled Ault Disruptive Technologies'average media sentiment score.

Company Overall Sentiment
Phoenix Biotech Acquisition Neutral
Ault Disruptive Technologies Neutral

Phoenix Biotech Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Ault Disruptive Technologies has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.

16.7% of Phoenix Biotech Acquisition shares are owned by institutional investors. Comparatively, 0.4% of Ault Disruptive Technologies shares are owned by institutional investors. 84.8% of Phoenix Biotech Acquisition shares are owned by insiders. Comparatively, 93.8% of Ault Disruptive Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Phoenix Biotech Acquisition and Ault Disruptive Technologies both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Phoenix Biotech AcquisitionN/AN/A
Ault Disruptive TechnologiesN/AN/A

Phoenix Biotech Acquisition's return on equity of 0.00% beat Ault Disruptive Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Phoenix Biotech AcquisitionN/A N/A N/A
Ault Disruptive Technologies N/A -37.45%2.52%

Summary

Phoenix Biotech Acquisition beats Ault Disruptive Technologies on 3 of the 5 factors compared between the two stocks.


Get Phoenix Biotech Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBAX vs. The Competition

MetricPhoenix Biotech AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$36.56M$255.47M$135.88M$7.55B
Dividend YieldN/A8.48%N/A3.86%
P/E RatioN/A2.342.2213.34
Price / SalesN/A14.771.41158.18
Price / CashN/A116.6168.9155.03
Price / BookN/A90.95353.264.60
Net IncomeN/A$12.91M$7.93M$207.21M
7 Day PerformanceN/A-0.79%0.03%-1.09%
1 Month Performance-47.01%-1.14%-1.94%3.27%
1 Year Performance-44.34%-1.25%-1.57%5.59%

Phoenix Biotech Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADRT
Ault Disruptive Technologies
0 of 5 stars
$11.99
+3.0%
N/AN/A$36.74MN/A0.00N/A
WAVS
Western Acquisition Ventures
0 of 5 stars
$10.68
+1.0%
N/A+3.4%$38.02MN/A0.00N/APositive News
MCAG
Mountain Crest Acquisition Corp. V
0 of 5 stars
$10.80
+0.1%
N/A+4.3%$34.24MN/A0.002,021
QOMO
Qomolangma Acquisition
0 of 5 stars
$10.93
+0.3%
N/AN/A$39.13MN/A0.00N/APositive News
High Trading Volume
OLIT
OmniLit Acquisition
0 of 5 stars
$5.53
+5.3%
N/A-48.9%$33.95MN/A0.002,021News Coverage
Gap Down
BRAC
Broad Capital Acquisition
0 of 5 stars
$11.22
flat
N/AN/A$33.55MN/A0.00N/A
TGVC
TG Venture Acquisition
0 of 5 stars
$10.79
flat
N/AN/A$41.22MN/A0.002,021
NOVV
Nova Vision Acquisition
0 of 5 stars
$11.65
flat
N/AN/A$41.57MN/A0.002,021Positive News
AIB
AIB Acquisition
0 of 5 stars
$11.56
flat
N/A+10.9%$41.73MN/A0.00N/A
GLST
Global Star Acquisition
0 of 5 stars
$10.66
+0.1%
N/A+4.1%$31.02MN/A0.00N/A

Related Companies and Tools

This page (NASDAQ:PBAX) was last updated on 2/25/2024 by MarketBeat.com Staff